Patients End-of-life choice means little without end-of-life support A strong end-of-life care system does not wait until the final days to step in.
Patients ASCO 2026: New hope in AL amyloidosis, with Dr Hans Lee A phase 1/2 trial in AL amyloidosis saw 100% of patients obtaining at least a very good partial response with 90% obtaining a complete response.
Patients Sponsored Designing global PSPs for the real world How integrating strategic design with implementation expertise can help create more scalable, locally relevant, and effective global PSPs.
Patients Is women’s health reaching an inflection point? A half-day symposium – titled Women’s Health: From Intractable to Investable – was held in London on 11th June, organised by Weatherden.
Patients Patient engagement drives clinical and commercial success Engagement solutions can tap into long-lasting patient motivations that sustain behaviour.
Patients Patient centricity beyond buzzwords: What works There is a strong emphasis on patient centricity, but, in many cases, patient engagement is just used to validate pre-existing assumptions.
Oncology ASCO 2026: All about DNA damage response, with Luke Piggot Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
